PharmaCyte Biotech

Quarterly Financials

Values in thousands 2025-07-31 2025-04-30 2025-01-31 2024-10-31
Revenue
$0
$0
$0
$0
EBITDA
-8,360
-960
-1,106
EBIT
-1,041
-1,041
-1,920
-2,213
Net Income
-8,360
11,749
-3,045
-1,470
Net Change In Cash
0
0
0
0
Free Cash Flow
-1,993
-1,040
-509
-1,054
Cash
13,178
15,172
16,383
20,840
Basic Shares
6,795
6,795
6,960
7,637

Annual Financials

Values in thousands 2025-04-30 2024-04-30 2023-04-30 2022-04-30
Revenue
$0
$0
$0
$0
EBITDA
30,656
333
-4,316
-4,239
EBIT
-4,377,862,000
-6,186
-10,771
-8,631
Net Income
30,656
333
-4,316
-4,239
Net Change In Cash
0
0
0
0
Free Cash Flow
-2,978
-2,151
-3,793
-4,117
Cash
15,172
50,179
68,039
85,400
Basic Shares
7,330
9,581
5,178
5,178

Earnings Calls

Quarter EPS
2025-10-31
$0
2025-07-31
-$1.23
2025-04-30
$1.58
2025-01-31
-$0.43